Literature DB >> 6820408

The use of deuterated phenylalanine for the in vivo assay of phenylalanine hydroxylase activity in children.

R Matalon, D E Matthews, K Michals, D Bier.   

Abstract

Fifteen children, five with phenylketonuria (PKU), five with hyperphenylalaninaemia, and five phenotypically normal but at risk of being carriers for PKU, were given [ring 2H5]phenylalanine orally in amounts ranging from 75 mg/kg to 10 mg/kg. Plasma was assayed for [2H5]phenylalanine and [2H4]tyrosine at hourly intervals, the amino acids being measured as the N-acetyl, n-propyl esters by gas chromatography-mass spectroscopy. The results obtained were calculated as the log of the ratio [2H5]phenylalanine: [2H4]tyrosine in the plasma. The five patients with PKU had ratios of infinity because no [2H4]tyrosine was measured in their plasma during the experimental period. The patients with hyperphenylalaninaemia had log ratios over 2.00 throughout the assay period. Among the five normal children three are considered to be carriers for PKU as the logarithms of the [2H5]phenylalanine: [2H4]tyrosine ratios were 1.77, 1.73, and 1.33 and remained over 1.00 during the assay period. The other children had log ratios of 1.16 and 1.00 at the first hour which dropped below 1.00 subsequently, suggesting normal activity of phenylalanine hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6820408     DOI: 10.1007/bf01799749

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  Malignant hyperphenylalaninaemia--current status (June 1977).

Authors:  D M Danks; K Bartholomé; B E Clayton; H Curtius; H Gröbe; S Kaufman; R Leeming; W Pfleiderer; H Rembold; F Rey
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

2.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

3.  Determination of stable isotopic enrichment in individual plasma amino acids by chemical ionization mass spectrometry.

Authors:  D E Matthews; E Ben-Galim; D M Bier
Journal:  Anal Chem       Date:  1979-01       Impact factor: 6.986

4.  The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.

Authors:  H C Curtius; J A Völlmin; K Baerlocher
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

5.  In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics.

Authors:  H C Curtius; M J Zagalak; K Baerlocher; J Schaub; W Leimbacher; U Redweik
Journal:  Helv Paediatr Acta       Date:  1978-02

6.  Sensitive in vivo assay of the phenylalanine hydroxylating system with a small intravenous dose of heptadeutero L-phenylalanine using high pressure liquid chromatography and capillary gas chromatography/mass fragmentography.

Authors:  F K Trefz; T Erlenmaier; D H Hunneman; K Bartholomé; P Lutz
Journal:  Clin Chim Acta       Date:  1979-12-17       Impact factor: 3.786

  6 in total
  4 in total

Review 1.  Atypical cases of phenylketonuria.

Authors:  J L Dhondt; J P Farriaux
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

2.  Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.

Authors:  G N Thompson; D Halliday
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  A study of the metabolism of [U-14C]3-methyl-2-oxopentanoate by rat liver mitochondria using h.p.l.c. with continuous on-line monitoring of radioactive intact acyl-coenzyme A intermediates.

Authors:  A G Causey; B Middleton; K Bartlett
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

Review 4.  An overview of phenylalanine and tyrosine kinetics in humans.

Authors:  Dwight E Matthews
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.